80 related articles for article (PubMed ID: 1402218)
1. Partial regression of vascular structural alterations in hypertensive patients treated with alpha-beta-blocker, labetalol.
Novo S; Abrignani MG; Sapienza ND; Barbagallo M; Pinto A; Di Maria GU; Mistretta A; Strano A
Int Angiol; 1992; 11(2):137-41. PubMed ID: 1402218
[TBL] [Abstract][Full Text] [Related]
2. Regression of structural vascular changes after chronic treatment in hypertensives.
Novo S; Abrignani MG; Liquori M; Corda M; Pinto A; Cosentino F; Strano A
J Hypertens Suppl; 1991 Dec; 9(6):S202-3. PubMed ID: 1818945
[No Abstract] [Full Text] [Related]
3. Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension.
Novo S; Pinto A; Galati D; Giannola A; Forte G; Strano A
Int Angiol; 1985; 4(2):229-34. PubMed ID: 2870124
[TBL] [Abstract][Full Text] [Related]
4. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
5. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
Serro-Azul JB; Wajngarten M; Santomauro A; Braga A; Yazbek Júnior P; Bellotti G; Serro-Azul LG; Pileggi F
Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
7. Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.
Lepäntalo MJ; Tötterman KJ
Int Angiol; 1985; 4(2):225-8. PubMed ID: 3831144
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Silke B; Nelson GI; Ahuja RC; Taylor SH
Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
[TBL] [Abstract][Full Text] [Related]
9. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
[TBL] [Abstract][Full Text] [Related]
10. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
12. Acute effect of labetalol on hypertensive brachial artery.
Pithois-Merli IM; Cournot AX; Georges DR; Pappo M; Safar ME
J Clin Hypertens; 1987 Dec; 3(4):479-86. PubMed ID: 3453384
[TBL] [Abstract][Full Text] [Related]
13. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
Hansen O; Johansson BW
J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
[TBL] [Abstract][Full Text] [Related]
14. Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
De Cesaris R; Grimaldi A; Balestrazzi M; Ranieri G; Chiarappa R; Avantaggiato F
Drugs Exp Clin Res; 1985; 11(10):725-9. PubMed ID: 3836858
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reduction and vascular adaptation. A study on long-term effects of treatment with mefruside or atenolol.
Sivertsson R; Andersson O; Hansson L
Acta Med Scand; 1979; 205(6):477-82. PubMed ID: 452941
[TBL] [Abstract][Full Text] [Related]
16. [The effect of acebutolol and metoprolol on noninvasive ambulatory blood pressure monitoring system in essential hypertension].
Kotake C; Koya Y; Ikeda S; Ikeda Y; Onaka H; Suyama K; Ichinohe T; Hayashi T; Kawaguchi K; Seo T
Kokyu To Junkan; 1992 Sep; 40(9):885-90. PubMed ID: 1439288
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol].
Forette F; Henry-Amar M; d'Allens H; Hervy MP; Bouchacourt P; Henry JF; Pappo M
Ann Cardiol Angeiol (Paris); 1987 Feb; 36(2):103-7. PubMed ID: 3827157
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
Baum T; Sybertz EJ
Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
[TBL] [Abstract][Full Text] [Related]
19. Beta blockers and renal function: a reappraisal.
Epstein M; Oster JR
J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
[TBL] [Abstract][Full Text] [Related]
20. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
